What is Wuhan Hiteck Biological Pharma Co Price-to-Operating-Cash-Flow?
As of today (2024-06-22), Wuhan Hiteck Biological Pharma Co's share price is ¥22.30.
Wuhan Hiteck Biological Pharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.26. Hence, Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow Ratio for today is 86.77.
The historical rank and industry rank for Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
SZSE:300683'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 29.07 Med: 68.61 Max: 657.74
Current: 86.77
During the past 11 years, Wuhan Hiteck Biological Pharma Co's highest Price-to-Operating-Cash-Flow Ratio was 657.74. The lowest was 29.07. And the median was 68.61.
Wuhan Hiteck Biological Pharma Co's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was ¥0.07.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.26.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Wuhan Hiteck Biological Pharma Co was -43.00% per year.
During the past 11 years, Wuhan Hiteck Biological Pharma Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 15.80% per year. The lowest was -45.60% per year. And the median was -25.65% per year.
Wuhan Hiteck Biological Pharma Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wuhan Hiteck Biological Pharma Co Price-to-Operating-Cash-Flow Chart
|
Wuhan Hiteck Biological Pharma Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
49.33 |
- |
522.46 |
85.10 |
880.73 |
|
Wuhan Hiteck Biological Pharma Co Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
81.93 |
132.10 |
- |
880.73 |
100.62 |
Competitive Comparison of Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow falls into.
Wuhan Hiteck Biological Pharma Co Price-to-Operating-Cash-Flow Calculation
Wuhan Hiteck Biological Pharma Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 22.30 | / | 0.257 |
| = | 86.77 |
Wuhan Hiteck Biological Pharma Co's Share Price of today is ¥22.30.
Wuhan Hiteck Biological Pharma Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description
Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300683 has been successfully added to your